| Management of Hepatocellular Carcinoma: An UpdateΔσ J Bruix, M Sherman Hepatology 53 (3), 1020-1022, 2011 | 9896 | 2011 |
| Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial MP Manns, JG McHutchison, SC Gordon, VK Rustgi, M Shiffman, ... The Lancet 358 (9286), 958-965, 2001 | 8330 | 2001 |
| Management of hepatocellular carcinoma J Bruix, M Sherman Hepatology 42 (5), 1208-1236, 2005 | 7204 | 2005 |
| Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference J Bruix, M Sherman, JM Llovet, M Beaugrand, R Lencioni, AK Burroughs, ... Journal of hepatology 35 (3), 421-430, 2001 | 5194 | 2001 |
| Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C JG McHutchison, SC Gordon, ER Schiff, ML Shiffman, WM Lee, VK Rustgi, ... New England Journal of Medicine 339 (21), 1485-1492, 1998 | 4566 | 1998 |
| Lamivudine for patients with chronic hepatitis B and advanced liver disease YF Liaw, JJY Sung, WC Chow, G Farrell, CZ Lee, H Yuen, T Tanwandee, ... New England Journal of Medicine 351 (15), 1521-1531, 2004 | 3146 | 2004 |
| Boceprevir for previously treated chronic HCV genotype 1 infection BR Bacon, SC Gordon, E Lawitz, P Marcellin, JM Vierling, S Zeuzem, ... New England Journal of Medicine 364 (13), 1207-1217, 2011 | 2239 | 2011 |
| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2136 | 2017 |
| Combination antiretroviral therapy and the risk of myocardial infarction Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group New England Journal of Medicine 349 (21), 1993-2003, 2003 | 2124 | 2003 |
| Telaprevir for retreatment of HCV infection S Zeuzem, P Andreone, S Pol, E Lawitz, M Diago, S Roberts, R Focaccia, ... New England Journal of Medicine 364 (25), 2417-2428, 2011 | 2118 | 2011 |
| Design and endpoints of clinical trials in hepatocellular carcinoma JM Llovet, AM Di Bisceglie, J Bruix, BS Kramer, R Lencioni, AX Zhu, ... Journal of the National Cancer Institute 100 (10), 698-711, 2008 | 2016 | 2008 |
| Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection N Afdhal, KR Reddy, DR Nelson, E Lawitz, SC Gordon, E Schiff, ... New England Journal of Medicine 370 (16), 1483-1493, 2014 | 1715 | 2014 |
| Hepatitis B e antigen and the risk of hepatocellular carcinoma HI Yang, SN Lu, YF Liaw, SL You, CA Sun, LY Wang, CK Hsiao, PJ Chen, ... New England Journal of Medicine 347 (3), 168-174, 2002 | 1706 | 2002 |
| Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C GL Davis, R Esteban-Mur, V Rustgi, J Hoefs, SC Gordon, C Trepo, ... New England journal of medicine 339 (21), 1493-1499, 1998 | 1593 | 1998 |
| Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ... The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018 | 1573 | 2018 |
| Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis KV Kowdley, SC Gordon, KR Reddy, L Rossaro, DE Bernstein, E Lawitz, ... New England Journal of Medicine 370 (20), 1879-1888, 2014 | 1510 | 2014 |
| Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection JG McHutchison, GT Everson, SC Gordon, IM Jacobson, M Sulkowski, ... New England Journal of Medicine 360 (18), 1827-1838, 2009 | 1430 | 2009 |
| Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options IM Jacobson, SC Gordon, KV Kowdley, EM Yoshida, M Rodriguez-Torres, ... New England journal of medicine 368 (20), 1867-1877, 2013 | 1429 | 2013 |
| Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon JH Hoofnagle, KD Mullen, DB Jones, V Rustgi, A Di Bisceglie, M Peters, ... New England Journal of Medicine 315 (25), 1575-1578, 1986 | 1370 | 1986 |
| Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update YF Liaw, JH Kao, T Piratvisuth, HLY Chan, RN Chien, CJ Liu, E Gane, ... Hepatology international 6, 531-561, 2012 | 1269 | 2012 |
